These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88. A Rare Case of Pleural Epithelioid Mesothelioma With a Prominent Myxoid Stroma Reported With Morphology, Fluorescent In Situ Hybridization, and Ultrastructural Findings. Sonobe H; Omote R; Habara T; Washio K; Yamazoe N; Matsumoto S; Nabeshima K; Toda H Cureus; 2024 Jun; 16(6):e62212. PubMed ID: 39006698 [TBL] [Abstract][Full Text] [Related]
89. Chylothorax in the Setting of Lung Malignancy. Vangara A; Haroon M; Kalafatis K; Kolagatla S; Ganti S; Prevatt O J Investig Med High Impact Case Rep; 2023; 11():23247096231192876. PubMed ID: 37565692 [TBL] [Abstract][Full Text] [Related]
90. A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis. Kinoshita Y; Hamasaki M; Yoshimura M; Matsumoto S; Sato A; Tsujimura T; Ueda H; Makihata S; Kato F; Iwasaki A; Nabeshima K Lung Cancer; 2018 Nov; 125():198-204. PubMed ID: 30429020 [TBL] [Abstract][Full Text] [Related]
91. CDKN2A and MTAP Are Useful Biomarkers Detectable by Droplet Digital PCR in Malignant Pleural Mesothelioma: A Potential Alternative Method in Diagnosis Compared to Fluorescence Cheng YY; Yuen ML; Rath EM; Johnson B; Zhuang L; Yu TK; Aleksova V; Linton A; Kao S; Clarke CJ; McCaughan BC; Takahashi K; Lee K Front Oncol; 2020; 10():579327. PubMed ID: 33304846 [TBL] [Abstract][Full Text] [Related]
92. Low homozygous/high heterozygous deletion status by p16 FISH correlates with a better prognostic group than high homozygous deletion status in malignant pleural mesothelioma. Hamasaki M; Matsumoto S; Abe S; Hamatake D; Kamei T; Hiroshima K; Kawahara K; Sato A; Tsujimura T; Nakatani Y; Yoshida Y; Iwasaki A; Nabeshima K Lung Cancer; 2016 Sep; 99():155-61. PubMed ID: 27565933 [TBL] [Abstract][Full Text] [Related]
93. The cytological features of effusions with mesothelioma in situ: A report of 9 cases. Michael CW; Bedrossian CCWM; Sadri N; Klebe S Diagn Cytopathol; 2023 Jun; 51(6):374-388. PubMed ID: 36942732 [TBL] [Abstract][Full Text] [Related]
94. Loss of BRCA1-associated protein 1 (BAP1) expression is useful in diagnostic cytopathology of malignant mesothelioma in effusions. Cozzi I; Oprescu FA; Rullo E; Ascoli V Diagn Cytopathol; 2018 Jan; 46(1):9-14. PubMed ID: 28994508 [TBL] [Abstract][Full Text] [Related]
95. A case of slowly progressive malignant pericardial mesothelioma suggesting the involvement of BAP1 loss. Fukasawa N; Agemi Y; Shiba A; Aga M; Hamakawa Y; Miyazaki K; Taniguchi Y; Misumi Y; Shimokawa T; Ono K; Hayashi H; Okamoto H Respirol Case Rep; 2022 Sep; 10(9):e01004. PubMed ID: 35950141 [TBL] [Abstract][Full Text] [Related]
96. Malignant Pleural Mesothelioma (MPM) Presenting as Hydropneumothorax. Kuramochi M; Muraoka T; Shinonaga M; Ohtani H; Kuraoka S Cureus; 2023 Jul; 15(7):e41243. PubMed ID: 37529811 [TBL] [Abstract][Full Text] [Related]
98. Hemizygous loss of NF2 detected by fluorescence in situ hybridization is useful for the diagnosis of malignant pleural mesothelioma. Kinoshita Y; Hamasaki M; Yoshimura M; Matsumoto S; Iwasaki A; Nabeshima K Mod Pathol; 2020 Feb; 33(2):235-244. PubMed ID: 31231129 [TBL] [Abstract][Full Text] [Related]
99. Malignant pleural mesothelioma presenting as low back pain: diagnosed by bone scan coordinating with F-18 FDG PET/CT. Huang YC; Tu DG; Wu JD; Lee MY Spine (Phila Pa 1976); 2009 Oct; 34(21):E780-3. PubMed ID: 19934799 [TBL] [Abstract][Full Text] [Related]
100. A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit. Segal A; Sterrett GF; Frost FA; Shilkin KB; Olsen NJ; Musk AW; Nowak AK; Robinson BW; Creaney J Pathology; 2013 Jan; 45(1):44-8. PubMed ID: 23222247 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]